Prenatal nutrition and the risk of adult obesity: Long-term effects of nutrition on epigenetic mechanisms regulating Gene expression

Journal of Nutritional Biochemistry

Volumn 39, Issue , 2017, Pages 1-14

  Navarro, Estanislau ^a   Funtikova, Anna N ^b,c,d   Fíto, Montserrat ^b,e   Schröder, Helmut ^b,c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

Epigenetic memory; Gestational programming; Nutrient sensors; Nutrition; O GlcNAcylation; Regulatory exhaustion

Indexed keywords

FOLIC ACID; HISTONE; AGOUTI PROTEIN; IGF2 PROTEIN, HUMAN; SOMATOMEDIN B;

ACETYLATION; CHROMATIN; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LOCUS; GENE STRUCTURE; GENETIC CODE; HUMAN; MATERNAL NUTRITION; MATERNAL OBESITY; NUTRIGENOMICS; PROTEIN PROCESSING; REVIEW; RISK ASSESSMENT; ADULT; BIOAVAILABILITY; DIET; FEMALE; GENETIC EPIGENESIS; GENETICS; MALNUTRITION; OBESITY; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; RISK FACTOR;

ADULT; AGOUTI SIGNALING PROTEIN; BIOLOGICAL AVAILABILITY; CHROMATIN; DIET; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALNUTRITION; NUTRIGENOMICS; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK FACTORS;

EID: 84964864646     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.03.012     Document Type: Review

References (263)

1. Lee B.C., Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 1842, 2014:446-462.
2. Navarro E., Funtikova A.N., Fito M., Schroder H. Can metabolically healthy obesity be explained by diet, genetics, and inflammation?. Mol Nutr Food Res 2015, 59:75-93.
3. Barker D.J. The fetal and infant origins of adult disease. BMJ 1990, 301:111.
4. Gut P., Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature 2013, 502:489-498.
5. Kermack W.O., McKendrick A.G., McKinlay P.L. Death-rates in Great Britain and Sweden: expression of specific mortality rates as products of two factors, and some consequences thereof. J Hyg (Lond) 1934, 34:433-457.
6. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease?. Br J Prev Soc Med 1977, 31:91-95.
7. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077-1081.
8. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577-580.
9. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
10. Hales C.N., Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. 1992. Int J Epidemiol 1992, 42:1215-1222.
11. Vickers M.H., Breier B.H., Cutfield W.S., Hofman P.L., Gluckman P.D. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000, 279:E83-E87.
12. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 2004, 430:419-421.
13. Calkins K., Devaskar S.U. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 2011, 41:158-176.
14. Hales C.N., Barker D.J. The thrifty phenotype hypothesis. Br Med Bull 2001, 60:5-20.
15. Langley-Evans S.C. Nutritional programming of disease: unravelling the mechanism. J Anat 2009, 215:36-51.
16. Ojha S., Saroha V., Symonds M.E., Budge H. Excess nutrient supply in early life and its later metabolic consequences. Clin Exp Pharmacol Physiol 2013, 40:817-823.
17. Singhal A., Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 2004, 363:1642-1645.
18. Singhal A., Kennedy K., Lanigan J., Fewtrell M., Cole T.J., Stephenson T., et al. Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trials. Am J Clin Nutr 2010, 92:1133-1144.
19. Wells J.C. Historical cohort studies and the early origins of disease hypothesis: making sense of the evidence. Proc Nutr Soc 2009, 68:179-188.
20. Ravelli G.P., Stein Z.A., Susser M.W. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976, 295:349-353.
21. Painter R.C., Roseboom T.J., Bleker O.P. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005, 20:345-352.
22. Ravelli A.C., van der Meulen J.H., Michels R.P., Osmond C., Barker D.J., Hales C.N., et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998, 351:173-177.
23. Ravelli A.C., van Der Meulen J.H., Osmond C., Barker D.J., Bleker O.P. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999, 70:811-816.
24. Roseboom T., de Rooij S., Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006, 82:485-491.
25. Veenendaal M.V., Painter R.C., de Rooij S.R., Bossuyt P.M., van der Post J.A., Gluckman P.D., et al. Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine. BJOG 2013, 120:548-553.
26. van Abeelen A.F., Elias S.G., Bossuyt P.M., Grobbee D.E., van der Schouw Y.T., Roseboom T.J., et al. Famine exposure in the young and the risk of type 2 diabetes in adulthood. Diabetes 2012, 61:2255-2260.
27. van Abeelen A.F., Veenendaal M.V., Painter R.C., de Rooij S.R., Dijkgraaf M.G., Bossuyt P.M., et al. Survival effects of prenatal famine exposure. Am J Clin Nutr 2012, 95:179-183.
28. Painter R.C., de Rooij S.R., Bossuyt P.M., Simmers T.A., Osmond C., Barker D.J., et al. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr 2006, 84:322-327. quiz 466-7.
29. van Abeelen A.F., Elias S.G., Bossuyt P.M., Grobbee D.E., van der Schouw Y.T., Roseboom T.J., et al. Cardiovascular consequences of famine in the young. Eur Heart J 2012, 33:538-545.
30. Lumey L.H., Martini L.H., Myerson M., Stein A.D., Prineas R.J. No relation between coronary artery disease or electrocardiographic markers of disease in middle age and prenatal exposure to the Dutch famine of 1944-5. Heart 2012, 98:1653-1659.
31. Huxley R.R., Neil H.A. Does maternal nutrition in pregnancy and birth weight influence levels of CHD risk factors in adult life?. Br J Nutr 2004, 91:459-468.
32. Stanner S.A., Bulmer K., Andres C., Lantseva O.E., Borodina V., Poteen V.V., et al. Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? results from the Leningrad siege study, a cross sectional study. BMJ 1997, 315:1342-1348.
33. Stanner S.A., Yudkin J.S. Fetal programming and the Leningrad siege study. Twin Res 2001, 4:287-292.
34. Rotar O., Moguchaia E., Boyarinova M., Kolesova E., Khromova N., Freylikhman O., et al. Seventy years after the siege of Leningrad: does early life famine still affect cardiovascular risk and aging?. J Hypertens 2015, 33:1772-1779. [discussion 9].
35. Yudkin J.S., Stanner S. Prenatal exposure to famine and health in later life. Lancet 1998, 351:1361-1362.
36. Ruemmele F.M., Garnier-Lengline H. Why are genetics important for nutrition? lessons from epigenetic research. Ann Nutr Metab 2012, 60(Suppl. 3):38-43.
37. Pembrey M., Saffery R., Bygren L.O. Human transgenerational responses to early-life experience: potential impact on development, health and biomedical research. J Med Genet 2014, 51:563-572.
38. Kaati G., Bygren L.O., Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet 2002, 10:682-688.
39. Bygren L.O., Tinghog P., Carstensen J., Edvinsson S., Kaati G., Pembrey M.E., et al. Change in paternal grandmothers' early food supply influenced cardiovascular mortality of the female grandchildren. BMC Genet 2014, 15:12. 10.1186/1471-2156-15-12.
40. Painter R.C., Osmond C., Gluckman P., Hanson M., Phillips D.I., Roseboom T.J. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 2008, 115:1243-1249.
41. Crick F.H. On protein synthesis. Symp Soc Exp Biol 1958, 12:138-163.
42. Brenner S., Jacob F., Meselson M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 1961, 190:576-581.
43. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
44. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
45. International. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
46. Pertea M., Salzberg S.L. Between a chicken and a grape: estimating the number of human genes. Genome Biol 2010, 11:206. 10.1186/gb-2010-11-5-206.
47. Shabalina S.A., Spiridonov N.A. The mammalian transcriptome and the function of non-coding DNA sequences. Genome Biol 2004, 5:105.
48. Adams M.D., Kerlavage A.R., Fleischmann R.D., Fuldner R.A., Bult C.J., Lee N.H., et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995, 377:3-174.
49. Korenberg J.R., Chen X.N., Adams M.D., Venter J.C. Toward a cDNA map of the human genome. Genomics 1995, 29:364-370.
50. Liang F., Holt I., Pertea G., Karamycheva S., Salzberg S.L., Quackenbush J. Gene index analysis of the human genome estimates approximately 120,000 genes. Nat Genet 2000, 25:239-240.
51. Carninci P., Waki K., Shiraki T., Konno H., Shibata K., Itoh M., et al. Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. Genome Res 2003, 13:1273-1289.
52. Carninci P. RNA dust: where are the genes?. DNA Res 2010, 17:51-59.
53. Costa F.F. Non-coding RNAs: Meet thy masters. Bioessays 2010, 32:599-608.
54. Wright M.W., Bruford E.A. Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics 2011, 5:90-98.
55. Consortium T.E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
56. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
57. Neph S., Vierstra J., Stergachis A.B., Reynolds A.P., Haugen E., Vernot B., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90.
58. Gerstein M.B., Kundaje A., Hariharan M., Landt S.G., Yan K.K., Cheng C., et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100.
59. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
60. Carninci P., Yasuda J., Hayashizaki Y. Multifaceted mammalian transcriptome. Curr Opin Cell Biol 2008, 20:274-280.
61. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
62. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014, 42:D68-D73.
63. Vidigal J.A., Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol 2015, 25:137-147.
64. Saki N., Abroun S., Soleimani M., Hajizamani S., Shahjahani M., Kast R.E., et al. Involvement of MicroRNA in T-Cell differentiation and Malignancy. Int J Hematol Oncol Stem Cell Res 2015, 9:33-49.
65. Hata A., Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal 2015, 8:re3. 10.1126/scisignal.2005825.
66. Andreou I., Sun X., Stone P.H., Edelman E.R. Feinberg MW. miRNAs in atherosclerotic plaque initiation, progression, and rupture. Trends Mol Med 2015, 21:307-318.
67. Schulte C., Zeller T. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther 2015, 5:17-36.
68. Descalzi G., Ikegami D., Ushijima T., Nestler E.J., Zachariou V., Narita M. Epigenetic mechanisms of chronic pain. Trends Neurosci 2015, 38:237-246.
69. Chung A.C., Lan H.Y. MicroRNAs in renal fibrosis. Front Physiol 2015, 6:50.
70. MacLellan S.A., MacAulay C., Lam S., Garnis C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol 2014, 14:27.
71. Papadopoulos T., Belliere J., Bascands J.L., Neau E., Klein J., Schanstra J.P. miRNAs in urine: a mirror image of kidney disease?. Expert Rev Mol Diagn 2015, 15:361-374.
72. Chevillet J.R., Kang Q., Ruf I.K., Briggs H.A., Vojtech L.N., Hughes S.M., et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A 2015, 111:14888-14893.
73. Simonson B., Das S. MicroRNA Therapeutics: the next magic bullet?. Mini Rev Med Chem 2015, 15:467-474.
74. Grote P., Herrmann B.G. Long noncoding RNAs in organogenesis: making the difference. Trends Genet 2015, 31:329-335.
75. Isin M., Dalay N. LncRNAs and neoplasia. Clin Chim Acta 2015, 444:280-288.
76. Haemmerle M., Gutschner T. Long non-coding RNAs in cancer and development: where do we go from here?. Int J Mol Sci 2015, 16:1395-1405.
77. Xie C., Yuan J., Li H., Li M., Zhao G., Bu D., et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res 2013, 42:D98-103.
78. Magistri M., Faghihi M.A., St Laurent G., Wahlestedt C. Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet 2012, 28:389-396.
79. Jiao A.L., Slack F.J. RNA-mediated gene activation. Epigenetics 2014, 9:27-36.
80. Lam M.T., Li W., Rosenfeld M.G., Glass C.K. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci 2014, 39:170-182.
81. Shibayama Y., Fanucchi S., Magagula L., Mhlanga M.M. lncRNA and gene looping. Transcription 2014, 5:e28658.
82. Jin B., Li Y., Robertson K.D. DNA methylation: Superior or subordinate in the epigenetic hierarchy?. Genes Cancer 2011, 2:607-617.
83. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057-1068.
84. Bartholomew B. Regulating the chromatin landscape: structural and mechanistic perspectives. Annu Rev Biochem 2014, 83:671-696.
85. Gurard-Levin Z.A., Almouzni G. Histone modifications and a choice of variant: a language that helps the genome express itself. F1000Prime Rep 2014, 6:76.
86. Barth T.K., Imhof A. Fast signals and slow marks: the dynamics of histone modifications. Trends Biochem Sci 2010, 35:618-626.
87. Rothbart S.B., Strahl B.D. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 1839, 2014:627-643.
88. Sadakierska-Chudy A., Kostrzewa R.M., Filip M. A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox Res 2015, 27:84-97.
89. Zhang G., Pradhan S. Mammalian epigenetic mechanisms. IUBMB Life 2014, 66:240-256.
90. Yost J.M., Korboukh I., Liu F., Gao C., Jin J. Targets in epigenetics: inhibiting the methyl writers of the histone code. Curr Chem Genomics 2011, 5:72-84.
91. Gillette T.G., Hill J.A. Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circ Res 2015, 116:1245-1253.
92. Patel D.J., Wang Z. Readout of epigenetic modifications. Annu Rev Biochem 2014, 82:81-118.
93. Miltenberger R.J., Mynatt R.L., Wilkinson J.E., Woychik R.P. The role of the agouti gene in the yellow obese syndrome. J Nutr 1997, 127:1902S-1907S.
94. Duhl D.M., Vrieling H., Miller K.A., Wolff G.L., Barsh G.S. Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994, 8:59-65.
95. Argeson A.C., Nelson K.K., Siracusa L.D. Molecular basis of the pleiotropic phenotype of mice carrying the hypervariable yellow (Ahvy) mutation at the agouti locus. Genetics 1996, 142:557-567.
96. Morgan H.D., Sutherland H.G., Martin D.I., Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 1999, 23:314-318.
97. Waterland R.A., Travisano M., Tahiliani K.G. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB J 2007, 21:3380-3385.
98. Vasicek T.J., Zeng L., Guan X.J., Zhang T., Costantini F., Tilghman S.M. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 1997, 147:777-786.
99. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T.J., Perry W.L., et al. The mouse fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-192.
100. Rakyan V.K., Chong S., Champ M.E., Cuthbert P.C., Morgan H.D., Luu K.V., et al. Transgenerational inheritance of epigenetic states at the murine axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci U S A 2003, 100:2538-2543.
101. Nordin M., Bergman D., Halje M., Engstrom W., Ward A. Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif 2014, 47:189-199.
102. Ludwig T., Eggenschwiler J., Fisher P., D'Ercole A.J., Davenport M.L., Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996, 177:517-535.
103. Keniry A., Oxley D., Monnier P., Kyba M., Dandolo L., Smits G., et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012, 14:659-665.
104. Kato Y., Sasaki H. Imprinting and looping: epigenetic marks control interactions between regulatory elements. Bioessays 2005, 27:1-4.
105. Ratajczak M.Z. Igf2-H19, an imprinted Tandem Yin-Yang gene and its emerging role in development, proliferation of Pluripotent stem cells, senescence and Cancerogenesis. J Stem Cell Res Ther 2012, 2.
106. Anderson O.S., Sant K.E., Dolinoy D.C. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem 2012, 23:853-859.
107. McKay J.A., Mathers J.C. Diet induced epigenetic changes and their implications for health. Acta Physiol (Oxf) 2011, 202:103-118.
108. Mathias P.C., Elmhiri G., de Oliveira J.C., Delayre-Orthez C., Barella L.F., Tofolo L.P., et al. Maternal diet, bioactive molecules, and exercising as reprogramming tools of metabolic programming. Eur J Nutr 2014, 53:711-722.
109. Wolff G.L., Kodell R.L., Moore S.R., Cooney C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998, 12:949-957.
110. Dolinoy D.C., Weidman J.R., Waterland R.A., Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006, 114:567-572.
111. Waterland R.A., Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003, 23:5293-5300.
112. Bultman S.J., Michaud E.J., Woychik R.P. Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204.
113. Klebig M.L., Wilkinson J.E., Geisler J.G., Woychik R.P. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A 1995, 92:4728-4732.
114. Mynatt R.L., Stephens J.M. Agouti regulates adipocyte transcription factors. Am J Physiol Cell Physiol 2001, 280:C954-C961.
115. Waterland R.A., Travisano M., Tahiliani K.G., Rached M.T., Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008, 32:1373-1379.
116. Waterland R.A., Dolinoy D.C., Lin J.R., Smith C.A., Shi X., Tahiliani K.G. Maternal methyl supplements increase offspring DNA methylation at axin fused. Genesis 2006, 44:401-406.
117. Cropley J.E., Suter C.M., Beckman K.B., Martin D.I. CpG methylation of a silent controlling element in the murine Avy allele is incomplete and unresponsive to methyl donor supplementation. PLoS One 2010, 5:e9055.
118. Dolinoy D.C., Weinhouse C., Jones T.R., Rozek L.S., Jirtle R.L. Variable histone modifications at the A(vy) metastable epiallele. Epigenetics 2010, 5:637-644.
119. Heijmans B.T., Tobi E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008, 105:17046-17049.
120. Bouwland-Both M.I., van Mil N.H., Stolk L., Eilers P.H., Verbiest M.M., Heijmans B.T., et al. DNA methylation of IGF2DMR and H19 is associated with fetal and infant growth: the generation R study. PLoS One 2013, 8:e81731.
121. Steegers-Theunissen R.P., Obermann-Borst S.A., Kremer D., Lindemans J., Siebel C., Steegers E.A., et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009, 4:e7845.
122. Tobi E.W., Lumey L.H., Talens R.P., Kremer D., Putter H., Stein A.D., et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 2009, 18:4046-4053.
123. Tobi E.W., Goeman J.J., Monajemi R., Gu H., Putter H., Zhang Y., et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun 2014, 5:5592.
124. Veenendaal M.V., Costello P.M., Lillycrop K.A., de Rooij S.R., van der Post J.A., Bossuyt P.M., et al. Prenatal famine exposure, health in later life and promoter methylation of four candidate genes. J Dev Orig Health Dis 2012, 3:450-457.
125. Fujimoto K., Polonsky K.S. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab 2009, 11(Suppl. 4):30-37.
126. Park J.H., Stoffers D.A., Nicholls R.D., Simmons R.A. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008, 118:2316-2324.
127. Abuzgaia A.M., Hardy D.B., Arany E. Regulation of postnatal pancreatic Pdx1 and downstream target genes after gestational exposure to protein restriction in rats. Reproduction 2015, 149:293-303.
128. Thompson R.F., Fazzari M.J., Niu H., Barzilai N., Simmons R.A., Greally J.M. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010, 285:15111-15118.
129. Zheng J., Xiao X., Zhang Q., Yu M., Xu J., Wang Z. Maternal protein restriction induces early-onset glucose intolerance and alters hepatic genes expression in the peroxisome proliferator-activated receptor pathway in offspring. J Diabetes Investig 2014, 6:269-279.
130. Zheng S., Pan Y.X. Histone modifications, not DNA methylation, cause transcriptional repression of p16 (CDKN2A) in the mammary glands of offspring of protein-restricted rats. J Nutr Biochem 2011, 22:567-573.
131. Zheng S., Rollet M., Yang K., Pan Y.X. A gestational low-protein diet represses p21(WAF1/Cip1) expression in the mammary gland of offspring rats through promoter histone modifications. Br J Nutr 2012, 108:998-1007.
132. Sandovici I., Smith N.H., Nitert M.D., Ackers-Johnson M., Uribe-Lewis S., Ito Y., et al. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci U S A 2011, 108:5449-5454.
133. Wronska A., Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf) 2015, 205:194-208.
134. Hilton C., Karpe F., Pinnick K.E. Role of developmental transcription factors in white, brown and beige adipose tissues. Biochim Biophys Acta 1851, 2015:686-696.
135. Oger F., Dubois-Chevalier J., Gheeraert C., Avner S., Durand E., Froguel P., et al. Peroxisome proliferator-activated receptor gamma regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes. J Biol Chem 2014, 289:708-722.
136. Lomax M.A., Sadiq F., Karamanlidis G., Karamitri A., Trayhurn P., Hazlerigg D.G. Ontogenic loss of brown adipose tissue sensitivity to beta-adrenergic stimulation in the ovine. Endocrinology 2007, 148:461-468.
137. Bispham J., Gardner D.S., Gnanalingham M.G., Stephenson T., Symonds M.E., Budge H. Maternal nutritional programming of fetal adipose tissue development: differential effects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferator-activated and prolactin receptors. Endocrinology 2005, 146:3943-3949.
138. Jousse C., Parry L., Lambert-Langlais S., Maurin A.C., Averous J., Bruhat A., et al. Perinatal undernutrition affects the methylation and expression of the leptin gene in adults: implication for the understanding of metabolic syndrome. FASEB J 2011, 25:3271-3278.
139. Masuyama H., Hiramatsu Y. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 2012, 153:2823-2830.
140. Romagnolo D.F., Zempleni J., Selmin O.I. Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention. Adv Nutr 2014, 5:373-385.
141. Keating S.T., El-Osta A. Epigenetics and metabolism. Circ Res 2015, 116:715-736.
142. Katada S., Imhof A., Sassone-Corsi P. Connecting threads: epigenetics and metabolism. Cell 2012, 148:24-28.
143. Sakabe K., Wang Z., Hart G.W. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A 2010, 107:19915-19920.
144. Hanover J.A., Krause M.W., Love D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 2012, 13:312-321.
145. Love D.C., Krause M.W., Hanover J.A. O-GlcNAc cycling: emerging roles in development and epigenetics. Semin Cell Dev Biol 2010, 21:646-654.
146. Zachara N.E., Hart G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673, 2004:13-28.
147. Walgren J.L., Vincent T.S., Schey K.L., Buse M.G. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am J Physiol Endocrinol Metab 2003, 284:E424-E434.
148. Hanover J.A., Krause M.W., Love D.C. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 1800, 2010:80-95.
149. Love D.C., Ghosh S., Mondoux M.A., Fukushige T., Wang P., Wilson M.A., et al. Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity. Proc Natl Acad Sci U S A 2010, 107:7413-7418.
150. Howerton C.L., Morgan C.P., Fischer D.B., Bale T.L. O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development. Proc Natl Acad Sci U S A 2013, 110:5169-5174.
151. Medford H.M., Chatham J.C., Marsh S.A. Chronic ingestion of a Western diet increases O-linked-beta-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart. Life Sci 2012, 90:883-888.
152. Gambetta M.C., Muller J. A critical perspective of the diverse roles of O-GlcNAc transferase in chromatin. Chromosoma 2015, 124:429-442.
153. Dehennaut V., Leprince D., Lefebvre T. O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins. Front Endocrinol (Lausanne) 2014, 5:155.
154. Chen Q., Chen Y., Bian C., Fujiki R., Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013, 493:561-564.
155. Zhang S., Roche K., Nasheuer H.P., Lowndes N.F. Modification of histones by sugar beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 2011, 286:37483-37495.
156. Ahmad W., Shabbiri K., Nazar N., Nazar S., Qaiser S., Shabbir Mughal M.A. Human linker histones: interplay between phosphorylation and O-beta-GlcNAc to mediate chromatin structural modifications. Cell Div 2011, 6:15.
157. Kerppola T.K. Polycomb group complexes-many combinations, many functions. Trends Cell Biol 2009, 19:692-704.
158. Gambetta M.C., Oktaba K., Muller J. Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Science 2009, 325:93-96.
159. Sinclair D.A., Syrzycka M., Macauley M.S., Rastgardani T., Komljenovic I., Vocadlo D.J., et al. Drosophila O-GlcNAc transferase (OGT) is encoded by the polycomb group (PcG) gene, super sex combs (sxc). Proc Natl Acad Sci U S A 2009, 106:13427-13432.
160. Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S., et al. GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 2011, 480:557-560.
161. Fong J.J., Nguyen B.L., Bridger R., Medrano E.E., Wells L., Pan S., et al. Beta-N-acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J Biol Chem 2012, 287:12195-12203.
162. Deplus R., Delatte B., Schwinn M.K., Defrance M., Mendez J., Murphy N., et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 2013, 32:645-655.
163. Lefebvre T., Dehennaut V., Guinez C., Olivier S., Drougat L., Mir A.M., et al. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease. Biochim Biophys Acta 1800, 2013:67-79.
164. Myslicki J.P., Shearer J., Hittel D.S., Hughey C.C., Belke D.D. O-GlcNAc modification is associated with insulin sensitivity in the whole blood of healthy young adult males. Diabetol Metab Syndr 2014, 6:96.
165. Vosseller K., Wells L., Lane M.D., Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3 T3-L1 adipocytes. Proc Natl Acad Sci U S A 2002, 99:5313-5318.
166. Keembiyehetty C., Love D.C., Harwood K.R., Gavrilova O., Comly M.E., Hanover J.A. Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis. J Biol Chem 2015, 290:7097-7113.
167. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A 2002, 99:10695-10699.
168. Lee J., Song E.Y., Chung T.W., Kang S.K., Kim K.S., Chung T.H., et al. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B. Arch Biochem Biophys 2004, 426:18-31.
169. Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2013, 45:51-60.
170. Schug T.T., Li X. Sirtuin 1 in lipid metabolism and obesity. Ann Med 2011, 43:198-211.
171. Kim S.Y., Sim C.K., Tang H., Han W., Zhang K., Xu F. Acetylome analysis Identifies SIRT1 targets in mRNA-Processing and Chromatin-Remodeling in mouse liver. PLoS One 2015, 10:e0140619.
172. McConnell M.J., Durand L., Langley E., Coste-Sarguet L., Zelent A., Chomienne C., et al. Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases. Epigenetics Chromatin 2015, 8:38.
173. Aguilar-Arnal L., Katada S., Orozco-Solis R., Sassone-Corsi P. NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1. Nat Struct Mol Biol 2015, 22:312-318.
174. Xue Z., Lv X., Song W., Wang X., Zhao G.N., Wang W.T., et al. SIRT1 deacetylates SATB1 to facilitate MAR HS2-MAR epsilon interaction and promote epsilon-globin expression. Nucleic Acids Res 2012, 40:4804-4815.
175. Posavec M., Timinszky G., Buschbeck M. Macro domains as metabolite sensors on chromatin. Cell Mol Life Sci 2013, 70:1509-1524.
176. Karras G.I., Kustatscher G., Buhecha H.R., Allen M.D., Pugieux C., Sait F., et al. The macro domain is an ADP-ribose binding module. EMBO J 2005, 24:1911-1920.
177. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
178. Meier J.L. Metabolic mechanisms of epigenetic regulation. ACS Chem Biol 2013, 8:2607-2621.
179. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
180. Jimenez-Chillaron J.C., Diaz R., Martinez D., Pentinat T., Ramon-Krauel M., Ribo S., et al. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 2012, 94:2242-2263.
181. Boyanapalli S.S., Tony Kong A.N. "curcumin, the King of Spices": epigenetic regulatory mechanisms in the prevention of cancer, Neurological, and inflammatory diseases. Curr Pharmacol Rep 2015, 1:129-139.
182. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004, 279:51163-51171.
183. Teiten M.H., Dicato M., Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 2013, 57:1619-1629.
184. Zamani M., Sadeghizadeh M., Behmanesh M., Najafi F. Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer. Phytomedicine 2015, 22:961-967.
185. Novak Kujundzic R., Grbesa I., Ivkic M., Katdare M., Gall-Troselj K. Curcumin downregulates H19 gene transcription in tumor cells. J Cell Biochem 2008, 104:1781-1792.
186. Ghosh S., Liu B., Zhou Z. Resveratrol activates SIRT1 in a Lamin A-dependent manner. Cell Cycle 2013, 12:872-876.
187. Gao Z., Xu M.S., Barnett T.L., Xu C.W. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem Biophys Res Commun 2011, 407:271-276.
188. Dhar S., Kumar A., Li K., Tzivion G., Levenson A.S. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta 1853, 2015:265-275.
189. Day J.K., Bauer A.M., DesBordes C., Zhuang Y., Kim B.E., Newton L.G., et al. Genistein alters methylation patterns in mice. J Nutr 2002, 132:2419S-2423S.
190. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008, 123:552-560.
191. Balasubramanyam K., Altaf M., Varier R.A., Swaminathan V., Ravindran A., Sadhale P.P., et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004, 279:33716-33726.
192. Heltweg B., Gatbonton T., Schuler A.D., Posakony J., Li H., Goehle S., et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 2006, 66:4368-4377.
193. Imai K., Kamio N., Cueno M.E., Saito Y., Inoue H., Saito I., et al. Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells. FEBS J 2014, 281:2148-2158.
194. Ho E., Clarke J.D., Dashwood R.H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr 2009, 139:2393-2396.
195. Ho E., Dashwood R.H. Dietary manipulation of histone structure and function. World Rev Nutr Diet 2010, 101:95-102.
196. Yiannakopoulou E.C. Targeting DNA methylation with green tea catechins. Pharmacology 2015, 95:111-116.
197. Gueant J.L., Namour F., Gueant-Rodriguez R.M., Daval J.L. Folate and fetal programming: a play in epigenomics?. Trends Endocrinol Metab 2013, 24:279-289.
198. Shorter K.R., Anderson V., Cakora P., Owen A., Lo K., Crossland J., et al. Pleiotropic effects of a methyl donor diet in a novel animal model. PLoS One 2014, 9:e104942.
199. Rakyan V.K., Blewitt M.E., Druker R., Preis J.I., Whitelaw E. Metastable epialleles in mammals. Trends Genet 2002, 18:348-351.
200. Graff J.R., Herman J.G., Myohanen S., Baylin S.B., Vertino P.M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997, 272:22322-22329.
201. Dolinoy D.C., Das R., Weidman J.R., Jirtle R.L. Metastable epialleles, imprinting, and the fetal origins of adult diseases. Pediatr Res 2007, 61:30R-37R.
202. Waterland R.A., Kellermayer R., Laritsky E., Rayco-Solon P., Harris R.A., Travisano M., et al. Season of conception in rural Gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet 2010, 6:e1001252.
203. Dominguez-Salas P., Moore S.E., Cole D., da Costa K.A., Cox S.E., Dyer R.A., et al. DNA methylation potential: dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women. Am J Clin Nutr 2013, 97:1217-1227.
204. Dominguez-Salas P., Moore S.E., Baker M.S., Bergen A.W., Cox S.E., Dyer R.A., et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun 2014, 5:3746.
205. Silver M.J., Kessler N.J., Hennig B.J., Dominguez-Salas P., Laritsky E., Baker M.S., et al. Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment. Genome Biol 2015, 16:118.
206. Whitelaw E., Martin D.I. Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 2001, 27:361-365.
207. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004, 20:63-68.
208. Druker R., Bruxner T.J., Lehrbach N.J., Whitelaw E. complex Patterns of transcription at the insertion site of a retrotransposon in the mouse. Nucleic Acids Res 2004, 32:5800-5808.
209. Yates P.A., Burman R.W., Mummaneni P., Krussel S., Turker M.S. Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem 1999, 274:36357-36361.
210. Yates P.A., Burman R., Simpson J., Ponomoreva O.N., Thayer M.J., Turker M.S. Silencing of mouse Aprt is a gradual process in differentiated cells. Mol Cell Biol 2003, 23:4461-4470.
211. Witwer K.W. XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles. RNA Biol 2012, 9:1147-1154.
212. Zhang L., Hou D., Chen X., Li D., Zhu L., Zhang Y., et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012, 22:107-126.
213. Baier S.R., Nguyen C., Xie F., Wood J.R., Zempleni J. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers. J Nutr 2014, 144:1495-1500.
214. Dickinson B., Zhang Y., Petrick J.S., Heck G., Ivashuta S., Marshall W.S. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013, 31:965-967.
215. Chen X., Zen K., Zhang C.Y. Reply to lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013, 31:967-969.
216. Witwer K.W. Diet-responsive mammalian miRNAs are likely endogenous. J Nutr 2014, 144:1880-1881.
217. Baier S.R., Nguyen C., Xie F., Wood J.R., Zempleni J. Reply to Witner. J Nutr 2014, 144:1881.
218. Witwer K.W., McAlexander M.A., Queen S.E., Adams R.J. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol 2013, 10:1080-1086.
219. Tosar J.P., Rovira C., Naya H., Cayota A. Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS. RNA 2014, 20:754-757.
220. Witwer K.W., Hirschi K.D. Transfer and functional consequences of dietary microRNAs in vertebrates: concepts in search of corroboration: negative results challenge the hypothesis that dietary xenomiRs cross the gut and regulate genes in ingesting vertebrates, but important questions persist. Bioessays 2014, 36:394-406.
221. Garcia-Segura L., Perez-Andrade M., Miranda-Rios J. The emerging role of MicroRNAs in the regulation of gene expression by nutrients. J Nutrigenet Nutrigenomics 2013, 6:16-31.
222. Palmer J.D., Soule B.P., Simone B.A., Zaorsky N.G., Jin L., Simone N.L. MicroRNA expression altered by diet: can food be medicinal?. Ageing Res Rev 2014, 17:16-24.
223. Crick F. Central dogma of molecular biology. Nature 1970, 227:561-563.
224. Paralkar V.R., Weiss M.J. Long noncoding RNAs in biology and hematopoiesis. Blood 2013, 121:4842-4846.
225. Dey B.K., Mueller A.C., Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription 2014, 5.
226. Liz J., Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta 2016, 1859:169-176.
227. Villegas V.E., Zaphiropoulos P.G. Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci 2015, 16:3251-3266.
228. Briggs S.F., Reijo Pera R.A. X chromosome inactivation: recent advances and a look forward. Curr Opin Genet Dev 2014, 28:78-82.
229. Schlesinger S., Goff S.P. Retroviral transcriptional regulation and embryonic stem cells: war and peace. Mol Cell Biol 2015, 35:770-777.
230. Watanabe T., Lin H. Posttranscriptional regulation of gene expression by Piwi proteins and piRNAs. Mol Cell 2014, 56:18-27.
231. Kim S., Yu N.K., Kaang B.K. CTCF as a multifunctional protein in genome regulation and gene expression. Exp Mol Med 2015, 47:e166.
232. Gatta R., Dolfini D., Zambelli F., Imbriano C., Pavesi G., Mantovani R. An acetylation-mono-ubiquitination switch on lysine 120 of H2B. Epigenetics 2011, 6:630-637.
233. Guillemette B., Drogaris P., Lin H.H., Armstrong H., Hiragami-Hamada K., Imhof A., et al. H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet 2011, 7:e1001354.
234. Karmodiya K., Krebs A.R., Oulad-Abdelghani M., Kimura H., Tora L. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics 2012, 13:424.
235. Gatta R., Mantovani R. Single nucleosome ChIPs identify an extensive switch of acetyl marks on cell cycle promoters. Cell Cycle 2010, 9:2149-2159.
236. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010, 107:21931-21936.
237. Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L., Shabanowitz J., et al. Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. J Biol Chem 2007, 282:7632-7640.
238. Cui K., Zang C., Roh T.Y., Schones D.E., Childs R.W., Peng W., et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009, 4:80-93.
239. de Wit E., Greil F., van Steensel B. High-resolution mapping reveals links of HP1 with active and inactive chromatin components. PLoS Genet 2007, 3.
240. Kimura H. Histone modifications for human epigenome analysis. J Hum Genet 2013, 58:439-445.
241. Kim H., Jang M.J., Kang M.J., Han Y.M. Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro. Hum Mol Genet 2010, 20:401-412.
242. Kim J., Kim H. Recruitment and biological consequences of histone modification of H3K27me3 and H3K9me3. ILAR J 2012, 53:232-239.
243. Agger K., Cloos P.A., Christensen J., Pasini D., Rose S., Rappsilber J., et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007, 449:731-734.
244. De Vries M., Ramos L., Housein Z., De Boer P. Chromatin remodelling initiation during human spermiogenesis. Biol Open 2012, 1:446-457.
245. Li Q., Sarna S.K. Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation. Am J Physiol Gastrointest Liver Physiol 2012, 303:G103-G110.
246. Kalakonda N., Fischle W., Boccuni P., Gurvich N., Hoya-Arias R., Zhao X., et al. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 2008, 27:4293-4304.
247. Botuyan M.V., Lee J., Ward I.M., Kim J.E., Thompson J.R., Chen J., et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006, 127:1361-1373.
248. Schotta G., Lachner M., Sarma K., Ebert A., Sengupta R., Reuter G., et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 2004, 18:1251-1262.
249. Regha K., Sloane M.A., Huang R., Pauler F.M., Warczok K.E., Melikant B., et al. Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol Cell 2007, 27:353-366.
250. Roseboom T.J., van der Meulen J.H., Ravelli A.C., van Montfrans G.A., Osmond C., Barker D.J., et al. Blood pressure in adults after prenatal exposure to famine. J Hypertens 1999, 17:325-330.
251. Roseboom T.J., van der Meulen J.H., Ravelli A.C., Osmond C., Barker D.J., Bleker O.P. Plasma fibrinogen and factor VII concentrations in adults after prenatal exposure to famine. Br J Haematol 2000, 111:112-117.
252. Roseboom T.J., van der Meulen J.H., Osmond C., Barker D.J., Ravelli A.C., Bleker O.P. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr 2000, 72:1101-1106.
253. Roseboom T.J., van der Meulen J.H., Osmond C., Barker D.J., Ravelli A.C., Schroeder-Tanka J.M., et al. Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45. Heart 2000, 84:595-598.
254. Roseboom T.J., Van Der Meulen J.H., Ravelli A.C., Osmond C., Barker D.J., Bleker O.P. Perceived health of adults after prenatal exposure to the Dutch famine. Paediatr Perinat Epidemiol 2003, 17:391-397.
255. Painter R.C., Roseboom T.J., van Montfrans G.A., Bossuyt P.M., Krediet R.T., Osmond C., et al. Microalbuminuria in adults after prenatal exposure to the Dutch famine. J Am Soc Nephrol 2005, 16:189-194.
256. de Rooij S.R., Painter R.C., Roseboom T.J., Phillips D.I., Osmond C., Barker D.J., et al. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 2006, 49:637-643.
257. Painter R.C., Roseboom T.J., Bossuyt P.M., Osmond C., Barker D.J., Bleker O.P. Adult mortality at age 57 after prenatal exposure to the Dutch famine. Eur J Epidemiol 2005, 20:673-676.
258. Painter R.C., de Rooij S.R., Bossuyt P.M., Phillips D.I., Osmond C., Barker D.J., et al. Blood pressure response to psychological stressors in adults after prenatal exposure to the Dutch famine. J Hypertens 2006, 24:1771-1778.
259. de Rooij S.R., Painter R.C., Phillips D.I., Osmond C., Michels R.P., Godsland I.F., et al. Impaired insulin secretion after prenatal exposure to the Dutch famine. Diabetes Care 2006, 29:1897-1901.
260. de Rooij S.R., Painter R.C., Holleman F., Bossuyt P.M., Roseboom T.J. The metabolic syndrome in adults prenatally exposed to the Dutch famine. Am J Clin Nutr 2007, 86:1219-1224.
261. Lumey L.H., Stein A.D., Kahn H.S., Romijn J.A. Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch hunger Winter families study. Am J Clin Nutr 2009, 89:1737-1743.
262. Painter R.C., de Rooij S.R., Hutten B.A., Bossuyt P.M., de Groot E., Osmond C., et al. Reduced intima media thickness in adults after prenatal exposure to the Dutch famine. Atherosclerosis 2007, 193:421-427.
263. Stein A.D., Kahn H.S., Rundle A., Zybert P.A., van der Pal-de Bruin K., Lumey L.H. Anthropometric measures in middle age after exposure to famine during gestation: evidence from the Dutch famine. Am J Clin Nutr 2007, 85:869-876.